Spectrum Plastics Group

Company Headquarters

2500 Northwinds Parkway
Suite 472
Alpharetta, GA 30009
United States

Company Description

Based in Alpharetta, Georgia with a global network of plants across the United States, Mexico, Canada, Costa Rica, Ireland and Malaysia; Spectrum Plastics Group is a leader in development through scaled manufacturing of critical polymer-based components and devices for medical and other demanding markets requiring quality, responsiveness, innovation and technical expertise. With 1,800+ Teammates, 20+ locations, and one million square feet of manufacturing space including Class 7 and Class 8 cleanrooms; Spectrum meets the requirements of ISO 9001 and ISO 13485 and has the resources to solve customers’ most challenging problems.

Buyer's Guide

    Content From Spectrum Plastics Group

    Related Content

    • Packaging & Sterilization
      Nelipak Appoints New CEO

      Nelipak Appoints New CEO

      Nelipak Chairman Roger Prevot will replace retiring CEO Michael Kelly.
      Nelipak Corporation 10.11.19

    • 3-D Printing/Additive Mfg. | Coatings/Surface Modification | Contract Manufacturing | Extremities | Finishing | Large Joint | Laser Processing | Machining & Tooling | Materials | Spine/Neurology
      Technology Revision: Changes in Implant Manufacturing

      Technology Revision: Changes in Implant Manufacturing

      Aspects of implant manufacturing are changing, enabling improved fabrication techniques with new material options.
      Mark Crawford, Contributing Writer 05.23.19

    • Spine/Neurology
      Medtronic Launches Japan

      Medtronic Launches Japan's First DBM Bone Grafting Product for Spine and Orthopedic Procedures

      Grafton DBM product will provide more options for spine and orthopedic surgeons in Japan.
      GlobeNewsire 02.28.19

    • Biologics
      Natural Selection: Biologics in Orthopedics

      Natural Selection: Biologics in Orthopedics

      With their healing prowess and cost-effectiveness, stem cells and bone graft substitutes are increasingly gaining traction in the orthobiologics sector.
      Michael Barbella, Managing Editor 02.13.19